FDA inspection report casts doubt on J&J vaccine contractor’s ability to restart production
The FDA report describes Emergent’s vaccine plant as “overcrowded” and “congested” leading to stacks of different materials near each other and difficulties navigating the floor without bumping into equipment. Inspectors…
Share